.After antibody-drug conjugate (ADC) expert Seagen was actually offered to Pfizer in 2013 for a mass...
.On the heels of a phase 3 win that fell short to wow investors, Ironwood Pharmaceuticals is back al...
.Don't stop Monte Rosa Rehabs now. The Boston-based biotech is enjoying after authorizing a handle N...
.Invite to today's Chutes & Ladders, our roundup of significant management hirings, shootings as ...
.Commemorating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer calle...
.AbbVie has gone back to the resource of its antipsychotic powerhouse Vraylar trying to find an addi...
.GenSight Biologics is full weeks away from losing amount of money. Once more. The biotech just poss...
.Monopar Rehabs is recovering a medicine coming from the dump of AstraZeneca's rare health condition...
.With brand-new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of exp...
.After forming a gene therapy partnership with Dyno Rehabs in 2020, Roche is actually back for more....